Navigation Links
DynaMed™ Joins with Guideline International Network to Improve the Quality of Healthcare
Date:7/17/2014

Ipswich, MA (PRWEB) July 17, 2014

DynaMed™ from EBSCO Health is collaborating with the Guidelines International Network (G-I-N) to promote the development and dissemination of evidence-based guidelines in order to improve the quality of healthcare. The evidence-based clinical decision support tool DynaMed aims to provide the most useful information to health care professionals at the point of care while G-I-N promotes the creation of high quality clinical practice guidelines that foster safe and effective patient care.

DynaMed is a valuable resource in the creation of guidelines. High-quality guideline development requires a lengthy process to identify, evaluate and summarize the current evidence to inform making recommendations. Development can take between 18-24 months and cost hundreds of thousands of dollars. Although DynaMed does not focus directly on guideline development the systematic processes used to identify, evaluate and summarize evidence for point-of-care use greatly overlaps with the development needs for high-quality guidelines.

This overlap was first used to produce a high-quality guideline quickly with a limited budget in 2010 in Costa Rica. A breast cancer guideline commissioned by Seguro Social (La Caja Costarricense de Seguro Social-CCSS), Costa Rica’s public health system, was completed in six months, and this was achieved by using DynaMed which had already identified the relevant evidence and provided critical appraisal and clinically relevant summaries of the evidence.

Brian S. Alper MD, MSPH, FAAFP (Founder of DynaMed) was asked to present this development at a G-I-N conference in 2012, introducing DynaMed and EBSCO Health to G-I-N. Interest in documenting this methodology and facilitating this guideline development support quickly grew across guideline developers from multiple countries, and G-I-N and EBSCO Health developed a collaborative agreement.

G-I-N is comprised of 100 organizations and 131 individual members representing 48 countries from all continents. G-I-N provides a network and partnerships for guideline organizations, implementers, end-users, researchers, students and other stakeholders. It promotes the systematic development of clinical practice guidelines and their application into practice in order to reduce inappropriate variation throughout the world.

Its goal is to reduce duplication of effort, while improving the efficiency of evidence-based guideline development, adaption, dissemination and implementation. G-I-N also looks to promote best practices through the development of opportunities for learning and building capacity and the establishment of high-quality standards of guideline development, adaptation, dissemination and implementation.

“G-I-N is delighted to enter into this collaborative agreement with DynaMed in order to provide a valuable resource to our members,” says G-I-N Executive Officer, Elaine Harrow. “We anticipate that this collaboration will bring tangible benefits, especially to those members, who may otherwise not have access to such a tool. G-I-N is the key connector of stakeholders in the guideline world and we view this collaboration as a great step forward in demonstrating the additional benefits we are endeavouring to bring to our members.”

DynaMed facilitates the dissemination of guidelines and includes listings of 14,000 guidelines, organized by topic, then by geographic region. It helps healthcare professionals to identify related guidelines and promotes better dissemination of guidelines by making them more accessible at the point of care. DynaMed also provides alerts when new evidence is introduced and that evidence may impact existing guidelines.

Each G-I-N member organization will receive five complimentary subscriptions to DynaMed. Dr. Alper will also be taking part in the 11th Annual G-I-N Conference in Melbourne, Australia in August. For more information about DynaMed, please visit: https://dynamed.ebscohost.com.

About EBSCO Health
EBSCO Health, part of EBSCO Information Services, is a leading provider of clinical decision support solutions, healthcare business intelligence, and medical research information for the healthcare industry. EBSCO Health users include professionals in medicine, nursing, and allied health. Flagship products include CINAHL®, DynaMed™, Nursing Reference Center™, clinical e-books and e-journals, EBSCO Discovery Service™, licensed databases (such as MEDLINE®), plus EBSCONET®. EBSCO databases are powered by EBSCOhost®, the electronic resource favored by libraries around the world.

About EBSCO Information Services
EBSCO Information Services (EBSCO) is the world’s premier database aggregator, offering a suite of more than 375 full-text and secondary research databases. Through a library of tens of thousands of full-text journals, magazines, books, monographs, reports and various other publication types from renowned publishers, EBSCO serves the content needs of all medical professionals (doctors, nurses, medical librarians, social workers, hospital administrators, etc.). The company’s product lines include proprietary databases such as CINAHL®, DynaMed™, Nursing Reference Center™, Patient Education Reference Center™, Rehabilitation Reference Center™, Rehabilitation & Sports Medicine Source™ and SocINDEX™ as well as dozens of leading licensed databases such as MEDLINE®, PsycARTICLES® and PsycINFO®. Databases are powered by EBSCOhost®, the most-used for-fee electronic resource in libraries around the world. For more information, visit the EBSCO website at: http://www.ebsco.com.

Read the full story at http://www.prweb.com/releases/G-I-N/DynaMed/prweb12024818.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. DynaMed™ and Nursing Reference Center™ Rated Higher Than Other Point-of-Care Reference Tools in New KLAS Report on Clinical Decision Support
2. IU Simon Cancer Center joins WellPoint in developing health care solutions
3. ACP joins Million Hearts to help save lives from preventable heart attacks and strokes
4. Gum disease joins hot flashes and PMS associated with womens hormones
5. Advertising Industry Veteran Pat McCrossan Joins Mangos
6. Rush joins elite group of institutions with accredited research programs
7. American Academy of Family Physicians joins AmericanEHR Partners
8. Test-Med Joins Forces with Mollen to Expand its Service Offerings to its Customers
9. Beige Fat Joins Brown Fat as Potential Weight-Loss Target
10. Adelaide joins with Italy to develop super spaghetti
11. Care New England joins The Conversation Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... California Senate Bill (SB) 863, signed into law in ... 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition , ... the study, medical payments per claim in California decreased 4 percent in 2013 and ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and financial planning services from offices headquartered in Hamilton County, is embarking on ... LuvFurMutts. , LuvFurMutts specializes in finding new homes for orphaned or neglected senior ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... ... 2016 , ... Kenall Manufacturing, a leader in sealed healthcare lighting for more ... a multi-function, sealed, LED luminaire that meets the needs of everyone in the patient ... , A 2’ x 4’ model features four modes: reading, ambient, standard ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... S.L. (“Presence”) for a purchase price of approximately $17.4 million (net of ... annual revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch ... gastroösophageale Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during ... Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)...  Boehringer Ingelheim announced today that it has been ... is the ninth time that the company received a ... Place to Work for LGBT Equality. Administered by the ... benchmarking report on corporate policies and practices related to ... employees. "We are committed to creating ...
Breaking Medicine Technology: